Li Jingliang is out of his fight against Michael Chiesa.
On the Chinese language social media platform Douyin (H/T Meni Mayer of MMA Suggestions), the UFC welterweight launched he turn out to be compelled to withdraw against Chiesa at UFC 287 due to the a backbone nervousness that would require surgical operation.
In his past six appearances, Jingliang has alternated between wins and losses. After returning to the procure column currently with a ‘Efficiency of the Evening’ awarded second-spherical TKO of Muslim Salikhov at UFC Prolonged Island in July, the ‘Leech’ lost a controversial destroy up resolution to Daniel Rodriguez at UFC 279 this past September.
Chiesa has now not fought since struggling a unanimous resolution loss to Sean Brady at UFC Vegas 43 over a year within the past. That turn out to be the second consecutive loss for the ‘Maverick,’ who also fell immediate against Vicente Luque.
Per Mike Heck of MMA Struggling with, the UFC is inquiring for a immediate-respect replacement for Chiesa. Among the many names who possess equipped to own in against the Final Fighter 15 winner turn out to be Kevin Lee, the currently re-signed UFC staple who already holds a first-spherical submission procure over Chiesa.
The ‘Motown Phenom’ claims his aged foe turned down the doable rematch. On the opposite hand, a representative for Chiesa says that turn out to be categorically deceptive.
“Or, factually, that is complete bulls—t and NOT A SINGLE NAME has been equipped as a replacement option but,” tweeted Daniel Rubenstein. “Tranquil to be definite if Chiesa stays on the UFC 287 card. My gut tells me him sharing the the same manager as Jingliang, his manager equipped to position him in and he turn out to be shot down.”
If no opponent is stumbled on for Chiesa, then UFC 287 moves forward with 13 fights. The upcoming pay-per-watch tournament goes down on Sat., April 8, at the Miami-Dade Enviornment in Miami, Fla.
About the creator: Kristen King is a author for Bloody Elbow. She has covered fight sports since 2016. (beefy bio)
